Paper17533129
Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
Casasnovas C and 4 others. Neuromuscul Disord, 2007. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness. Papers, record 17533129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17533129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Muscle Weakness | Major topic |
| Myasthenia Gravis | Major topic |
| Neck Muscles | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Cholinergic | Major topic |
| Action Potentials | |
| Antibodies | |
| Electric Stimulation | |
| Electromyography | |
| Female | |
| Humans | |
| Middle Aged |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42729421 | Dropped head syndrome as the sole presenting manifestation of probable post-cytomegalovirus immune-mediated brainstem encephalitis in an immunocompetent woman: a case report. | Front Immunol | 2026 | https://conductscience.org/library/papers/42729421 | PubMed |
| 40787458 | A pilot study of the immunological profile and efficacy of rituximab in muscle-specific kinase antibody-positive myasthenia gravis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40787458 | PubMed |
| 36793652 | Is paravertebral muscles edema a consequence of neurogenic changes in MuSK-positive myasthenia gravis? | Acta Myol | 2022 | https://conductscience.org/library/papers/36793652 | PubMed |
| 33458590 | Myasthenia gravis: MuSK MG, late-onset MG and ocular MG. | Acta Myol | 2020 | https://conductscience.org/library/papers/33458590 | PubMed |
| 29655451 | Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies. | Neurol Clin | 2018 | https://conductscience.org/library/papers/29655451 | PubMed |
| 23376659 | Dropped head with positive intravenous edrophonium, progressing to myasthenia gravis. | BMJ Case Rep | 2013 | https://conductscience.org/library/papers/23376659 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MUSK | 4593 | PubTator's text mining | https://conductscience.org/library/genes/4593 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17533129
GET https://conductscience.org/api/papers/v1/17533129/authors